Cohesys develops novel biocompatible adhesives for surgical applications.
Cohesys has raised $367K in total funding. The most recent round was Seed. The last funding was announced in July 2024.
Cohesys's investors include Creative Destruction Lab (CDL), University of Toronto, Toronto Innovation Acceleration Partners, UTEST, Ministry of Economic Development, Job Creation and Trade.
Cohesys is headquartered in Toronto, Canada.
Cohesys develops novel biocompatible adhesives for surgical applications.
Cohesys is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cohesys — Funding & Investors." VCBacked, July 8, 2024, https://www.vcbacked.co/company/cohesys. Accessed September 16, 2026.
VCBacked. (2024). Cohesys — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/cohesys
{{cite web |title=Cohesys — Funding & Investors |url=https://www.vcbacked.co/company/cohesys |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated